Methylmalonic acid

Metabolism

Methylmalonic acid is a by-product of the propionate metabolism pathway. The starting sources for this are the following with the respective approximate contributions to whole body propionate metabolism in brackets:

• essential amino acids: methionine, valine, threonine and isoleucine (~ 50%)
• odd-chain fatty acids (~ 30%)
• propionic acid from bacterial fermentation (~ 20%)
• cholesterol side chain
• thymine The propionate derivative, propionyl-CoA, is converted into D-methylmalonyl-CoA by propionyl-CoA carboxylase and then converted into L-methylmalonyl-CoA by methylmalonyl-CoA epimerase. Entry into the citric acid cycle occurs through the conversion of L-methylmalonyl-CoA into succinyl-CoA by L-methylmalonyl-CoA mutase, whereby vitamin B12 in the form of adenosylcobalamin is required as a coenzyme. This degradation pathway from propionyl-CoA to succinyl-CoA represents one of the most important anaplerotic pathways of the citric acid cycle. Methylmalonic acid is formed as a by-product of this metabolic pathway when D-methylmalonyl-CoA is cleaved into methylmalonic acid and CoA by D-methylmalonyl-CoA hydrolase. The enzyme acyl-CoA synthetase family member 3 (ACSF3) is in turn responsible for the conversion of methylmalonic acid and CoA to methylmalonyl-CoA.

Clinical relevance

Vitamin B₁₂ deficiency

Main article: Vitamin B12 deficiency

Increased methylmalonic acid levels may indicate a vitamin B12 deficiency. The test is highly sensitive (those with vitamin B12 deficiency almost always have raised levels) but not very specific (those that do not have vitamin B12 deficiency may have raised levels too). Methylmalonic acid is elevated in 90–98% of patients with vitamin B12 deficiency. It has lower specificity since 20–25% of patients over the age of 70 have elevated levels of methylmalonic acid, but 25–33% of them do not have B12 deficiency. For this reason, the testing of methylmalonic acid levels is not routinely recommended in the elderly.

Metabolic diseases

An excess is associated with methylmalonic acidemias.

If elevated methylmalonic acid levels are accompanied by elevated malonic acid levels, this may indicate the metabolic disease combined malonic and methylmalonic aciduria (CMAMMA). By calculating the malonic acid to methylmalonic acid ratio in blood plasma, CMAMMA can be distinguished from classic methylmalonic acidemia.

Cancer

Moreover, methylmalonic acid accumulation in the blood with age has been linked with tumour progression in 2020.

Bacterial overgrowth in the small intestine

Bacterial overgrowth in the small intestine can also lead to elevated levels of methylmalonic acid due to the competition of bacteria in the absorption process of vitamin B12. This is true of vitamin B12 from food and oral supplementation and can be circumvented by vitamin B12 injections. It is also hypothesized from case studies of patients with short bowel syndrome that intestinal bacterial overgrowth leads to increased production of propionic acid, which is a precursor to methylmalonic acid. It has been shown that in these cases, methylmalonic acid levels returned to normal with the administration of metronidazole.

Biomarker for nitrous oxide toxicity

Nitrous oxide oxidizes the cobalt in vitamin B12. When B12 -dependent methylmalonyl-CoA mutase is disrupted, methylmalonic acid accumulates in the blood. Methylmalonic acid reliably reflects B12 deficiency in instances where B12 in serum or plasma is normal. (Strongly) elevated methylmalonic acid correlates with neuropathy and myelopathy, and it is a reliable biomarker during recovery or active (chronic) N2O abuse.

Measurement

Methylmalonic acid concentrations in blood are measured by gas chromatographic mass spectrometry or liquid chromatography–mass spectrometry (LC-MS) and the expected values of methylmalonic acid in healthy people are between 73 and 271 nmol/L.

References

References

1. "Dissociation Constants Of Organic Acids And Bases". ZirChrom Separations, Inc..
2. (March 2024). "Methylmalonic acid in aging and disease". Trends in Endocrinology & Metabolism.
3. (September 2005). "Genetic and genomic systems to study methylmalonic acidemia". Molecular Genetics and Metabolism.
4. (September 2014). "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia". Orphanet Journal of Rare Diseases.
5. (1988). "Branched-Chain Amino Acids". Elsevier.
6. (2023-10-31). "Methylmalonyl Coenzyme A (CoA) Epimerase Deficiency, an Ultra-Rare Cause of Isolated Methylmalonic Aciduria With Predominant Neurological Features". Cureus.
7. (July 2020). "Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes". Molecular Genetics and Metabolism.
8. "ACSF3 gene".
9. "Sensitivity and Specificity". Emory University School of Medicine.
10. "B12 Deficiency and Dizziness".
11. (2016). "A New Approach for Fast Metabolic Diagnostics in CMAMMA". Springer Berlin Heidelberg.
12. (September 2020). "Age-induced accumulation of methylmalonic acid promotes tumour progression". Nature.
13. (February 2007). "Small Intestinal Bacterial Overgrowth". Gastroenterology & Hepatology.
14. (February 1972). "Competition between bacteria and intrinsic factor for vitamin B 12: implications for vitamin B 12 malabsorption in intestinal bacterial overgrowth". Gastroenterology.
15. (April 2009). "Vitamin B12 status, methylmalonic acidemia, and bacterial overgrowth in short bowel syndrome". Journal of Pediatric Gastroenterology and Nutrition.
16. (January 2018). "Is Serum Methylmalonic Acid a Reliable Biomarker of Vitamin B12 Status in Children with Short Bowel Syndrome: A Case Series". The Journal of Pediatrics.
17. Grzych, Guillaume. (2023-04-01). "Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study". Journal of Neurology.
18. (2007). "The role of poor nutritional status and hyperhomocysteinemia in complicated pregnancy in Syria".
19. "Methylmalonic Acid, Serum or Plasma (Vitamin B12 Status)".